MedPath

sefulness of Suppository of Seasame Seads and Seasame Oil in Inflammation of Pelvis

Not Applicable
Completed
Conditions
Health Condition 1: N739- Female pelvic inflammatory disease, unspecified
Registration Number
CTRI/2021/01/030182
Lead Sponsor
ational Institute Of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women diagnosed with clinical features of uncomplicated pelvic inflammatory disease (adnexal and cervical motion tenderness, pelvic discomfort, lower abdominal pain, abnormal vaginal discharge, low backache, dyspareunia, dysuria) and other clinical features of uPID (mild/subclinical PID

Exclusion Criteria

Complicated cases of PID ((pelvic or tubo-ovarian abscess) and/or any condition likely to require surgical intervention within 24 hours of the start of treatment.).

Women with any malignancy and systemic disease.

Women on contraceptive (OCPs and IUCD).

Pregnancy and lactation.

Delivery and abortion within last three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in modified McCormack pain scale for abdominal tenderness and VAS pain scale for lower abdominal pain and other clinical features (abnormal vaginal discharge, lowbackache, dyspareunia, etc)Timepoint: Follow up of the patient will be done on 8th, 15th day during treatment and one follow up on 30th day without treatment from baseline.
Secondary Outcome Measures
NameTimeMethod
Change in SF-12 HRQoL questionnaireTimepoint: Follow up of the patient will be done on 15th day during treatment and one follow up on 30th day without treatment from baseline
© Copyright 2025. All Rights Reserved by MedPath